Latest news with #SN1


BBC News
19-05-2025
- Climate
- BBC News
Reduced water flow in homes due to burst main in Swindon
Some properties are experiencing reduced water flow as engineers work to repair a burst water Water said it found the burst pipe, which is located between The Croft and Wichelstowe in Swindon, on Sunday evening and those in the SN1, SN3 and SN4 postcodes were water supplier said tankers were being used and it was adjusting their network to bring water from other areas to reduce disruption."You may see lower pressure than normal during peak usage times and we apologise for this inconvenience to your morning," it said. "We know how inconvenient it is if you lose your water supply, so we'll work hard to get things back to normal as soon as we can," Thames Water added.


Business Upturn
15-05-2025
- Business
- Business Upturn
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and BigBear and Encourages Investors to Contact the Firm
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ibotta, Inc. (NYSE:IBTA), NET Power, Inc. (NYSE:NPWR), Zenas BioPharma, Inc. (NASDAQ:ZBIO) and Holdings, Inc. (NYSE:BBAI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Ibotta, Inc. (NYSE:IBTA) Class Period: In connection with Ibotta's April 18, 2024 initial public offering Lead Plaintiff Deadline: June 16, 2025 The Complaint alleges that in connection with the Initial Public Offering on April 18, 2024, Ibotta issued a registration statement that contained false and/or misleading statements or omissions. Specifically, the Complaint alleges that: (1) The registration statement failed to warn investors of the risks concerning Ibotta's contract with The Kroger Co. ('Kroger'); (2) Kroger's contract was at-will, and Ibotta failed to warn investors that a large client could cancel their contract with Ibotta without warning. Despite providing a detailed explanation of the terms of Ibotta's contract with another large customer, there was not a single warning of the at-will nature of Kroger's contract; (3) Rather than disclosing the very real risk of a major client walking away at any time, Ibotta provided boilerplate warnings concerning the importance of maintaining ongoing relationships with their clients; (4) By August 13, 2024, Kroger was no longer listed as a client in Ibotta's SEC filings; and (5) The price of Ibotta's securities has plummeted since the IPO, devastating investors. Currently, Ibotta stock trades significantly lower than the IPO price of $88.00 per share. For more information on the Ibotta class action go to: NET Power, Inc. (NYSE:NPWR) Class Period: June 9, 2023 – March 7, 2025 Lead Plaintiff Deadline: June 17, 2025 Net Power is a clean energy technology company. Its business is centered around its so-called 'Net Power Cycle' technology, which is a purported novel power generation system designed to produce reliable and affordable electricity from natural gas while capturing virtually all atmospheric emissions. Net Power has a facility located in La Porte, Texas, which it uses to demonstrate the viability of the NET Power Cycle, referred to as 'La Porte' or the 'Demonstration Plant.' Net Power conducts research and equipment validation testing campaigns at the Demonstration Plant as part of its efforts to develop its first utility-scale plant, which it variably refers to as 'SN1' or 'Project Permian.' Project Permian is located at a site in the Permian Basin of West Texas. Since before the start of the Class Period, Defendants had represented that they anticipated SN1 to be operational in 2026. In 2023, Net Power's cost estimate for Project Permian was roughly $950 million, which increased to $1.1 billion in 2024. Net Power's commencement of commercial operations and, accordingly, its business and financial prospects, rely on its completion of Project Permian. As such, Defendants' projected timelines and cost estimates for Project Permian are of particular importance to investors and analysts. The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Net Power was unlikely to complete Project Permian on schedule, and the project was likely to be significantly more expensive than Defendants had represented, because of, inter alia, supply chain issues and numerous site- and region-specific challenges; (ii) accordingly, Defendants' projections regarding the time and capital needed to complete Project Permian were unrealistic; (iii) the increased time and capital needed to complete Project Permian were likely to have a significant negative impact on the Company's business and financial results; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times. For more information on the NET Power class action go to: Zenas BioPharma, Inc. (NASDAQ:ZBIO) Class Period: Pursuant and/or traceable to the registration statement and related prospectus issued in connection with Zenas BioPharma's September 2024 initial public offering Lead Plaintiff Deadline: June 16, 2025 The Complaint alleges that the Registration Statement issued in connection with the Company's initial public offering (the 'IPO' or 'Offering') contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time that it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, Defendants public statements were materially false and misleading at all relevant times and negligently prepared. For more information on the Zenas BioPharma class action go to: Holdings, Inc. (NYSE:BBAI) Class Period: March 31, 2022 – March 25, 2025 Lead Plaintiff Deadline: June 10, 2025 The lawsuit alleges that Defendants made materially false and/or misleading statements, and/or failed to disclose material adverse facts regarding business, operations, and prospects, including allegations that: (i) BigBear maintained deficient accounting review policies related to the reporting and disclosure of certain non-routine, unusual, or complex transactions; (ii) as a result, the Company incorrectly determined that the conversion option within the 2026 Convertible Notes qualified for the derivative scope exception under ASC 815-40 and failed to bifurcate the conversion option as required by ASC 815-15; (iii) accordingly, BigBear had improperly accounted for the 2026 Convertible Notes; (iv) the foregoing error caused BigBear to misstate various items in several of the Company's previously issued financial statements; (v) as a result, these financial statements were inaccurate and would likely need to be restated; (vi) BigBear would require extra time and expense to correct the inaccurate financial statements, thereby increasing the risk that the Company would be unable to timely file certain financial reports with the SEC; and (vii) as a result, the Company's public statements were materially false and misleading at all relevant times. For more information on the BigBear class action go to: About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information: Bragar Eagel & Squire, Walker, Esq. Marion Passmore, Esq.(212) 355-4648 [email protected]


USA Today
30-04-2025
- Sport
- USA Today
Bo Bichette Player Props: April 30, Blue Jays vs. Red Sox
Bo Bichette Player Props: April 30, Blue Jays vs. Red Sox Bo Bichette and the Toronto Blue Jays will play Lucas Giolito and the Boston Red Sox on Wednesday at 7:07 p.m. ET on SN1 and NESN. Bichette had two hits in his last game, going 2-for-4 with a double. Find odds, stats, and more below to make your Bo Bichette player prop bets. Bichette has nine doubles and five walks while batting .290. Watch tonight's Blue Jays game on Fubo! Bo Bichette Prop Bets and Odds Hits Prop: 1.5 hits (Over odds: +140) 1.5 hits (Over odds: +140) Home Runs Prop: 0.5 home runs (Over odds: +725) 0.5 home runs (Over odds: +725) RBI Prop: 0.5 RBI (Over odds: +170) 0.5 RBI (Over odds: +170) Runs Prop: 0.5 runs (Over odds: -111) 0.5 runs (Over odds: -111) Total Bases Prop: 1.5 total bases (Over odds: -118) 1.5 total bases (Over odds: -118) Stolen Bases Prop: 0.5 stolen bases (Over odds: +650) How to Watch Toronto Blue Jays vs. Boston Red Sox Matchup: Toronto Blue Jays vs. Boston Red Sox Toronto Blue Jays vs. Boston Red Sox Time: 7:07 p.m. ET 7:07 p.m. ET Date: Wednesday, April 30, 2025 Wednesday, April 30, 2025 TV Channel: SN1 and NESN SN1 and NESN Live Stream: Fubo (Watch now! - Regional restrictions may apply) Bo Bichette vs. Lucas Giolito Over his career versus Lucas Giolito, Bichette is 5-for-14 with two doubles and a home run. Bo Bichette prop bet insights In 69% of his games this year (20 of 29), Bichette has recorded a hit, and in 11 of those games (37.9%) he's recorded at least two base hits. In the 29 games he's appeared in this season he has not yet hit a home run. Bichette has scored at least one run 10 times this season in 29 games played (34.5%), including one multi-run effort. He has tallied at least one RBI in 10 of 29 games played this season (34.5%), including two games with multiple RBI. In 12 of 29 games this year (41.4%), Bichette has gone down on strikes, and five of those games (17.2%) included an effort that resulted in two or more strikeouts. MLB odds courtesy of BetMGM Sportsbook. Odds updated Wednesday at 6:25 p.m. ET. For a full list of sports betting odds, access USA TODAY Sports Betting Scores Odds Hub. Bo Bichette stats against the Red Sox Red Sox starter: Lucas Giolito


USA Today
27-04-2025
- Sport
- USA Today
Blue Jays vs. Padres Tickets, First Pitch Time for Tuesday, May 20
Blue Jays vs. Padres Tickets, First Pitch Time for Tuesday, May 20 Manny Machado and Tyler Heineman will take the field when the San Diego Padres and Toronto Blue Jays meet on Tuesday, May 20 at Rogers Centre (on SN1 and SDPA). Buy Blue Jays Tickets on SeatGeek Buy Blue Jays Tickets on StubHub Blue Jays vs. Padres Game Info Game day: Tuesday, May 20, 2025 Tuesday, May 20, 2025 Game time: 7:07 p.m. ET 7:07 p.m. ET TV channel: SN1 and SDPA SN1 and SDPA Live Stream: Watch LIVE with Fubo! (Regional restrictions may apply) Watch LIVE with Fubo! Location: Toronto, Ontario Toronto, Ontario Stadium: Rogers Centre Rogers Centre Blue Jays Starter: TBA TBA Padres Starter: TBA Blue Jays vs. Padres Tickets For Sale Blue Jays vs. Padres offensive insights The Blue Jays have hit just 14 homers this season, which ranks 29th in the league. Hitters for Toronto have combined to rank 26th in MLB with a slugging percentage of only .348 this season. The Blue Jays' .242 batting average ranks 14th in the league this season. The Padres are 19th in baseball with 24 home runs. They average 0.9 per game. So far this year, San Diego's .392 slugging percentage is 12th in the majors. The Padres have the fourth-best batting average in the majors (.257). Watch MLB on Fubo Blue Jays' top hitters Vladimir Guerrero Jr.'s batting average this year is .278, and he has a .377 on-base percentage and a .402 slugging percentage. He has two homers and 11 RBI, plus 10 runs scored. His strikeout rate is 16.7%, and his walk rate is 13.2%. In 2025, Bo Joseph Bichette is hitting .292, with a .693 OPS (.331 on-base, .363 slugging). He has no home runs and 13 RBI, plus nine runs scored and two steals on three attempts. His strikeout rate is 13.2%, and his walk rate is 4.1%. George Springer is hitting .329, with two home runs and 12 RBI, plus 10 runs scored and three steals on three attempts. He has a .932 OPS (.412 on-base, .521 slugging). His strikeout rate is 24.4%, and his walk rate is 12.8%. Also for the Blue Jays, Andres Gimenez's batting average is .189, with a .611 OPS (.284 on-base, .326 slugging). He has three homers and eight RBI, plus 15 runs scored and eight stolen bases on nine attempts. His strikeout rate is 18.3%, and his walk rate is 8.3%. Padres' top hitters Fernando Tatis Jr. has posted a .347 batting average along with a .412 OBP and .634 SLG in 114 plate appearances this season. He's also clubbed eight home runs with 18 RBI and 23 runs, including seven steals, while putting up a 14.9% K% and 10.5% BB%. In 110 plate appearances this season, Machado is hitting .280/.345/.440 with two home runs, 10 RBI and 17 runs, with six stolen bases on six attempts. He's fanning at a 15.5% clip and walking 9.1% of the time. So far this season, the Padres' Xander Bogaerts owns a .239/.330/.326 triple slash line, and he's smashed no homers with 10 runs scored and five RBI plus four stolen bases on four attempts. He's walking and striking out 11.3% and 21.7% of the time, respectively. At the dish, the Padres' Gavin Sheets has a .276/.317/.447 triple slash line, and he's blasted three homers with seven runs scored and 12 RBI. He's walking and striking out 6.1% and 28% of the time, respectively. Blue Jays' injuries Daulton Varsho: 10 Day IL (Shoulder), Ryan Matthew Burr: 15 Day IL (Shoulder), Erik Swanson: 15 Day IL (Hand), Max Scherzer: 15 Day IL (Lat), Nick Sandlin: 15 Day IL (Back), Alek Manoah: 60 Day IL (Elbow), Angel Bastardo: 60 Day IL (Elbow) Padres' injuries Jacob John Cronenworth: 10 Day IL (Rib), Jason Heyward: 10 Day IL (Knee), Brandon Lockridge: 10 Day IL (Hamstring), Jackson Merrill: 10 Day IL (Hamstring), Yu Darvish: 15 Day IL (Elbow), Sean Reynolds: 15 Day IL (Foot), Bryan Hoeing: 15 Day IL (Shoulder), Jhony Brito: 60 Day IL (Forearm), Matt Waldron: 60 Day IL (Oblique), Joe Musgrove: 60 Day IL (Elbow), Luis Sangel (Reveron) Arraez: 7 Day IL (Concussion protocol) Buy Blue Jays Tickets on SeatGeek Buy Blue Jays Tickets on StubHub


USA Today
21-04-2025
- Sport
- USA Today
Blue Jays vs. Rays Tickets, First Pitch Time for Wednesday, May 14
Blue Jays vs. Rays Tickets, First Pitch Time for Wednesday, May 14 Bo Joseph Bichette and the Toronto Blue Jays will attempt to defeat Kameron Misner and the Tampa Bay Rays when the teams square off on Wednesday, May 14 at 7:07 p.m. ET, airing on SN1 and FDSSUN. Buy Blue Jays Tickets on SeatGeek Buy Blue Jays Tickets on StubHub Blue Jays vs. Rays Game Info Game day: Wednesday, May 14, 2025 Wednesday, May 14, 2025 Game time: 7:07 p.m. ET 7:07 p.m. ET TV channel: SN1 and FDSSUN SN1 and FDSSUN Live Stream: Watch LIVE with Fubo! (Regional restrictions may apply) Watch LIVE with Fubo! Location: Toronto, Ontario Toronto, Ontario Stadium: Rogers Centre Rogers Centre Blue Jays Starter: TBA TBA Rays Starter: TBA Blue Jays vs. Rays Tickets For Sale Blue Jays vs. Rays offensive insights The Blue Jays' 12 home runs rank second-to-last in MLB this season. Hitters for Toronto have combined for a team rank of 22nd in the majors with a .368 team slugging percentage. The Blue Jays' .259 batting average is among the best in baseball, ranking fourth in MLB. The Rays are 19th in baseball with 21 home runs. They average one per game. This season, Tampa Bay is 10th in the majors, slugging .399. The Rays have the fifth-best batting average in the majors (.258). Watch MLB on Fubo Blue Jays' top hitters Bichette is batting .313 this year, with a .356 on-base percentage and a .396 slugging percentage. His strikeout rate is 14.4%, and his walk rate is 4.8%. He has no home runs and 13 RBI, plus nine runs scored and two steals on three attempts. In 2025, Vladimir Guerrero Jr.'s batting average is .305, to go along with a .408 on-base percentage and a .415 slugging percentage. He has one homer and 10 RBI, plus eight runs scored. His strikeout rate is 14.3%, and his walk rate is 14.3%. Andres Gimenez's current batting average is .205, and he has three home runs and eight RBI, plus 14 runs scored and seven steals on eight attempts. His strikeout rate is 17.9%, and his walk rate is 8.4%. He has a .295 on-base percentage, and a .361 slugging percentage. The Blue Jays' George Springer is hitting .344, with a .972 OPS (.414 on-base, .557 slugging). His strikeout rate is 25.4%, and his walk rate is 11.3%. He has two home runs and 11 RBI, plus nine runs scored and one steal on one attempt. Rays' top hitters The Rays' Jonathan Aranda sports a .355/.438/.677 triple slash line this season, and he's blasted four home runs with 12 runs and 13 RBI. He's walking and striking out 12.3% and 16.4% of the time, respectively. In 57 plate appearances, Misner is batting .360/.404/.660 this season with a walk rate of 7% and a strikeout rate of 15.8%. Additionally, he's swatted three home runs while knocking in 10 runs and scoring 10 times. Plus, he's swiped one bag on one try. This season, Junior Caminero, who sports a .269/.310/.500 triple slash line, has piled up 14 runs, 11 RBI, and five dingers in 84 plate appearances. His walk rate is 6%, while his strikeout rate is 23.8%. At the plate, Yandy (Fernandez) Diaz has put up a batting average of .222 with an OPS of .635 (.268 OBP; .367 SLG) this season, while slugging three homers with 10 runs and eight RBI. He's drawing free passes at a 6.2% clip and fanning 13.4% of the time. Blue Jays' injuries Daulton Varsho: 10 Day IL (Shoulder), Ryan Matthew Burr: 15 Day IL (Shoulder), Erik Swanson: 15 Day IL (Hand), Max Scherzer: 15 Day IL (Lat), Nick Sandlin: 15 Day IL (Back), Alek Manoah: 60 Day IL (Elbow), Angel Bastardo: 60 Day IL (Elbow) Rays' injuries Richard Palacios: 10 Day IL (Knee), Ha-Seong Kim: 10 Day IL (Shoulder), Josh Lowe: 10 Day IL (Oblique), Jonny Deluca: 10 Day IL (Shoulder), Kevin Kelly: 15 Day IL (Glute), Shane McClanahan: 15 Day IL (Tricep), Nathan Lavender: 60 Day IL (Elbow), Alex Faedo: 60 Day IL (Shoulder) Buy Blue Jays Tickets on SeatGeek Buy Blue Jays Tickets on StubHub